1. Home
  2. MBIN vs AUPH Comparison

MBIN vs AUPH Comparison

Compare MBIN & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIN

Merchants Bancorp

HOLD

Current Price

$49.11

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.45

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIN
AUPH
Founded
1990
1993
Country
United States
Canada
Employees
735
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MBIN
AUPH
Price
$49.11
$16.45
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$43.67
$17.25
AVG Volume (30 Days)
89.2K
1.1M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
0.89%
N/A
EPS Growth
N/A
5075.00
EPS
N/A
0.25
Revenue
N/A
$283,055,000.00
Revenue This Year
$31.76
$17.54
Revenue Next Year
$3.73
$15.74
P/E Ratio
$12.29
$65.72
Revenue Growth
N/A
20.38
52 Week Low
$28.75
$7.29
52 Week High
$51.00
$16.88

Technical Indicators

Market Signals
Indicator
MBIN
AUPH
Relative Strength Index (RSI) 57.40 60.55
Support Level $44.97 $14.60
Resistance Level $50.26 $16.88
Average True Range (ATR) 1.43 0.52
MACD 0.13 0.07
Stochastic Oscillator 65.52 86.17

Price Performance

Historical Comparison
MBIN
AUPH

About MBIN Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: